Medistim

Earnings Release • Oct 23, 2015

Results for third quarter 2015 for Medistim ASA

Results for third quarter 2015 for Medistim ASA

Sales ended at MNOK 61.6 for the quarter (MNOK 52.0),

an 18.5 % growth. Sales as of September increased by

18.9 % and ended at MOK 176.8 (MNOK 148.7).

Operating profit (EBIT) for the quarter ended at MNOK

12.7 (MNOK 10.0). Operating profit as of September

ended at MNOK 34.3 (MNOK 28.9) after an accrual of

MNOK 3.2 related to termination of the Medtronic

agreement.

Profit per share increased with 32 % for the quarter

and ended at NOK 0.57 (NOK 0.43). As of September

profit per share was NOK1.56 (NOK 1.12).

The positive development in USA continues with a

currency neutral growth of 6.7 % for the quarter.

Currency neutral growth as of September was 10.7 %.

Medistim introduced its new product within vascular

surgery in the 3rd quarter.